Portuguese and Spanish universities have adopted well-defined royalty sharing schedules over the last fifteen years. We investigate whether such royalty sharing schedules have been effective in stimulating inventors' efforts and in ultimately improving university outcomes. We base our empirical analysis on university-level data and two new self-collected surveys for both inventors and Technology Transfer Offices (TTOs). Evidence from the inventors' survey indicates that one third of respondents are incentivised by current royalty sharing schedules, one third could be incentivised by higher royalty shares, and the remaining third is totally insensitive to royalty sharing. Plain regressions on university level datasets suggest that the incentive effects documented by the inventors' survey fail to translate into increased patenting or licensing income. It would seem that inventor royalty shares are not as influential as they could be, due to the poor commercial prospects of university inventions. Among other possible reasons, these poor prospects appear to reflect the fact that inventors are unable to produce potentially licensable inventions, or that eventually TTOs may not be focussing enough on commercialising their inventions.
We study whether there is scope for using subsidies to smooth out barriers to R&D performance and expand the share of R&D firms in Spain. We consider a dynamic model with sunk entry costs in which firms' optimal participation strategy is defined in terms of two subsidy thresholds that characterize entry and continuation. We compute the subsidy thresholds from the estimates of a dynamic panel data type-2 tobit model for an unbalanced panel of about 2,000 Spanish manufacturing firms. The results suggest that "extensive" subsidies are a feasible and efficient tool for expanding the share of R&D firms.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.